RecruitingNCT04203979
Sepsis: From Syndrome to Personalized Care
Sponsor
Oslo University Hospital
Enrollment
1,950 participants
Start Date
Jan 6, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective, observational study designed to examine the performance of biomarkers, molecular biological methods and other analysis in blood from patient with suspected sepsis in the Emergency department, as well as identidying novel sepsis endotypes. Around 1500 patients will be enrolled.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- admitted to emergency department OUH, Ullevål.
- managed by the medical rapid response team or the sepsis rapid response team
Exclusion Criteria1
- Not given informed consent by patient or next of kin (if patient is not able to)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04203979
Related Trials
Emergency PWAS in Respiratory Infectious Disease
NCT053368511 location
Evaluation of the Clinical Frailty Scale (CFS) as a Risk Factor of Mortality in Adult Patients ≤65 Years of Age Admitted to Intensive Care for Septic Shock.
NCT059287675 locations
Validation of SOFA-2 for Mortality and Sepsis-3 Prevalence in Turkey
NCT073003061 location
UMMS Sepsis Early Prediction Score (SEPSys) and RESCUE Score Combined Clinical Trial
NCT067796178 locations
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
NCT0721570271 locations